Cassava Sciences Issues Statement on Former Science Advisor
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Jones Trading Downgrades Cassava Sciences (SAVA) to Hold, 'Multiple Uncertainties'
July 1, 2024 9:43 AM EDTJones Trading analyst Soumit Roy downgraded Cassava Sciences (NASDAQ: SAVA) from Buy to Hold.
The analyst comments "Following the federal grand jury indictment of the former consultant of Cassava Sciences, Dr. Hoau-Yan Wang, last Friday (link), and today's 8-K (link) mentioning the... More
